Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Laccetti
Effects of a Second-Generation Human Anti-ErbB2 ImmunoRNase on Trastuzumab-Resistant Tumors and Cardiac Cells
Protein Engineering, Design and Selection
Biochemistry
Bioengineering
Molecular Biology
Biotechnology
Related publications
Two Novel Human Anti-ErbB2 Immunoagents Are Active on Trastuzumab-Resistant Tumours
British Journal of Cancer
Cancer Research
Oncology
The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
A Novel Toll-Like Receptor 9 Agonist Cooperates With Trastuzumab in Trastuzumab-Resistant Breast Tumors Through Multiple Mechanisms of Action
Clinical Cancer Research
Cancer Research
Oncology
Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells
PLoS ONE
Multidisciplinary
Nectin-4 Cis-Interacts With ErbB2 and Its Trastuzumab-Resistant Splice Variants, Enhancing Their Activation and DNA Synthesis
Scientific Reports
Multidisciplinary
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Inhibitors of HSP90 Block P95-Her2 Signaling in Trastuzumab-Resistant Tumors and Suppress Their Growth
Oncogene
Cancer Research
Genetics
Molecular Biology
Anti-Atherosclerotic Effects of Sirolimus on Human Vascular Smooth Muscle Cells
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
